These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 24015183)
1. Geldanamycin-induced osteosarcoma cell death is associated with hyperacetylation and loss of mitochondrial pool of heat shock protein 60 (hsp60). Gorska M; Marino Gammazza A; Zmijewski MA; Campanella C; Cappello F; Wasiewicz T; Kuban-Jankowska A; Daca A; Sielicka A; Popowska U; Knap N; Antoniewicz J; Wakabayashi T; Wozniak M PLoS One; 2013; 8(8):e71135. PubMed ID: 24015183 [TBL] [Abstract][Full Text] [Related]
2. The Major Heat Shock Proteins, Hsp70 and Hsp90, in 2-Methoxyestradiol-Mediated Osteosarcoma Cell Death Model. Gorska-Ponikowska M; Kuban-Jankowska A; Marino Gammazza A; Daca A; Wierzbicka JM; Zmijewski MA; Luu HH; Wozniak M; Cappello F Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963524 [TBL] [Abstract][Full Text] [Related]
3. 17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines. Massimini M; Palmieri C; De Maria R; Romanucci M; Malatesta D; De Martinis M; Maniscalco L; Ciccarelli A; Ginaldi L; Buracco P; Bongiovanni L; Della Salda L Vet Pathol; 2017 May; 54(3):405-412. PubMed ID: 28438108 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence. Marino Gammazza A; Campanella C; Barone R; Caruso Bavisotto C; Gorska M; Wozniak M; Carini F; Cappello F; D'Anneo A; Lauricella M; Zummo G; Conway de Macario E; Macario AJ; Di Felice V Cancer Lett; 2017 Jan; 385():75-86. PubMed ID: 27836734 [TBL] [Abstract][Full Text] [Related]
5. HSP90 protects apoptotic cleavage of vimentin in geldanamycin-induced apoptosis. Zhang MH; Lee JS; Kim HJ; Jin DI; Kim JI; Lee KJ; Seo JS Mol Cell Biochem; 2006 Jan; 281(1-2):111-21. PubMed ID: 16328963 [TBL] [Abstract][Full Text] [Related]
6. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma. Hu Y; Bobb D; He J; Hill DA; Dome JS Cancer Biol Ther; 2015; 16(6):949-57. PubMed ID: 25920748 [TBL] [Abstract][Full Text] [Related]
7. Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells. Mori M; Hitora T; Nakamura O; Yamagami Y; Horie R; Nishimura H; Yamamoto T Int J Oncol; 2015 Jan; 46(1):47-54. PubMed ID: 25351442 [TBL] [Abstract][Full Text] [Related]
8. Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway. Shu X; Liu H; Zhen R; Jie Y; Chen L; Qi H; Wang C; Wang R; Chen D; Ran Y Oncol Rep; 2020 Jul; 44(1):313-324. PubMed ID: 32377704 [TBL] [Abstract][Full Text] [Related]
9. Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells. Lee CS; Kim YJ; Lee SA; Myung SC; Kim W Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):173-81. PubMed ID: 22433057 [TBL] [Abstract][Full Text] [Related]
10. Hsp90 inhibitor geldanamycin enhances the antitumor efficacy of enediyne lidamycin in association with reduced DNA damage repair. Han FF; Li L; Shang BY; Shao RG; Zhen YS Asian Pac J Cancer Prev; 2014; 15(17):7043-8. PubMed ID: 25227788 [TBL] [Abstract][Full Text] [Related]
11. Targeted therapy of human osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways. Gazitt Y; Kolaparthi V; Moncada K; Thomas C; Freeman J Int J Oncol; 2009 Feb; 34(2):551-61. PubMed ID: 19148492 [TBL] [Abstract][Full Text] [Related]
12. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation. Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706 [TBL] [Abstract][Full Text] [Related]
13. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells. Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586 [TBL] [Abstract][Full Text] [Related]
14. Licochalcone A-Induced Apoptosis Through the Activation of p38MAPK Pathway Mediated Mitochondrial Pathways of Apoptosis in Human Osteosarcoma Cells In Vitro and In Vivo. Lin RC; Yang SF; Chiou HL; Hsieh SC; Wen SH; Lu KH; Hsieh YH Cells; 2019 Nov; 8(11):. PubMed ID: 31739642 [TBL] [Abstract][Full Text] [Related]
15. Geldanamycin inhibits trichostatin A-induced cell death and histone H4 hyperacetylation in COS-7 cells. Huang HC; Liu YC; Liu SH; Tzang BS; Lee WC Life Sci; 2002 Mar; 70(15):1763-75. PubMed ID: 12002521 [TBL] [Abstract][Full Text] [Related]
16. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway. Dai G; Zheng D; Guo W; Yang J; Cheng AY Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353 [TBL] [Abstract][Full Text] [Related]
17. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation. Wang J; Li Z; Lin Z; Zhao B; Wang Y; Peng R; Wang M; Lu C; Shi G; Shen Y Cancer Lett; 2015 Jun; 362(1):83-96. PubMed ID: 25813406 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling. Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940 [TBL] [Abstract][Full Text] [Related]
19. Calycosin induces apoptosis via p38‑MAPK pathway‑mediated activation of the mitochondrial apoptotic pathway in human osteosarcoma 143B cells. Tian W; Wang ZW; Yuan BM; Bao YG Mol Med Rep; 2020 Nov; 22(5):3962-3968. PubMed ID: 32901836 [TBL] [Abstract][Full Text] [Related]
20. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma. Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]